END7 - Eliminating 7 Diseases by 2020
One in six people, including half a billion children, are infected with neglected tropical diseases (NTDs). Most people have never heard of these diseases, but they have devastating effects. END7 was launched to raise awareness and funds to help eliminate the seven most common NTDs by 2020.
END7 will help to raise awareness and funds to help reach elimination goals by 2020.
Sabin Foundation Europe
Without treatment, neglected tropical diseases (NTDs) can lead to blindness, malnutrition, anaemia and other severe physical and cognitive disabilities. They can make children too sick to go to school and can prevent adults from working and caring for their families. Studies have shown the children consistently treated for NTDs are more likely to attend school and to earn higher wages as adults.
A simple packet of pills can treat and prevent infection from all seven diseases. The pills are distributed to the entire community once or twice a year through a process known as mass drug administration (MDA), until the diseases are eliminated. Because pharmaceutical companies donate most of the pills, the cost to treat and protect one person for up to a year is on average only 50p.
Raise funds to support NTD control programmes in Africa, Asia and Latin America and the Caribbean.
Activities» Raise funds to treat 50,000 children. For more information about the impact this will have, check out www.end7.org and www.facebook.com/endseven.
END7 will grant the funds to implementers working on NTD treatment programmes in Africa, Asia or Latin America. We work with a range of implementing organisations in these regions.
Conducting mass drug administrations in endemic communities will lead to better health outcomes and promote economic advancement for those who have or are at risk of contracting neglected tropical diseases.
Because the medicine needed to treat the diseases are safe, effective, and mostly donated by the pharmaceutical companies, there is a real opportunity to eliminate all seven NTDs as public health threats by 2020 if we can help ensure those medicines make it to those in need.
It may take several rounds of mass drug administration before the diseases are eliminated from a community. As a result, providing sustainable funding sources is essential to ensuring that individuals and communities can actually break free of the burden imposed by these diseases. Thus, the major risk is re-infection if a community does not receive annual treatment until the diseases are eliminated.
We work with a range of implementing organisations, all of which have been vetted to ensure they deliver top quality programmes. At the 6-month point and one year, we will provide a report of how the funds have been used. Donors can also follow treatment developments on www.facebook.com/endseven.
Budget - Project Cost: £20,000Loading graph....
Amount Heading Description £20,000 Treatment for NTDs Provides treatment and prevention to approximately 50,000 people
The funding will support a neglected tropical disease treatment programme in Africa, Asia or Latin America. These diseases are widespread among people in poor, rural communities and END7 will work with our implementing partners to deliver an effective treatment programme in an area with high disease burden. Sabin Foundation Europe, based in the U.K., is partnering with the Sabin Vaccine Institute, based in the U.S., on the END7 project.
The primary beneficiaries are people at risk of contracting neglected tropical diseases (NTDs) in Africa, Asia and Latin America and the Caribbean – the three regions with the highest NTD burdens. In total, one in six people, including half a billion children, are affected by NTDs.
However, as our world becomes ever more connected, the regions affected by these diseases may expand. As a result, individuals in other countries may also benefit from neglected tropical disease control.
Sabin Foundation Europe (SFE) supports vaccine development, advocacy efforts, and treatment programmes that improve the lives of the world’s poor. SFE also supports efforts to raise awareness and funding for NTD control through END7. END7 is a public/private partnership that seeks to catalyse grassroots support for NTD control efforts.
Importantly, 100 percent of donations to the END7 campaign will go to NTD treatment programmes in Asia, Africa and Latin America and the Caribbean.
Read more about the Charity running this project.
Dr. Peter J. Hotez, President, Sabin Vaccine Institute
Dr. Hotez is president of the Sabin Vaccine Institute and the founding dean of the National School of Tropical Medicine at Baylor College of Medicine.
Dr. Neeraj Mistry, Managing Director, Global Network For Neglected Tropical Diseases
A public health physician, Dr. Mistry has extensive experience in global health policy and programming in the public and private sectors.